Clinical Data's Q1 Revenues Rise 52 Percent; PGx Division up 7 Percent

During the quarter, the firm launched two new Familion genetic tests while preparing for the potential launch of its first drug.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories